HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chromosome damage by dothistromin in human peripheral blood lymphocyte cultures: a comparison with aflatoxin B1.

Abstract
The clastogenic potential of the pine tree fungal toxin dothistromin was studied by metaphase chromosome analysis of stimulated human peripheral blood lymphocytes exposed in vitro. The frequency of gaps, breaks, deletions and exchanges was scored in a series of cultures from 3 different donors. 50 cells were analysed for each dose level on coded slides. Testing was performed with and without added metabolic activation (as S9 mix) and aflatoxin B1 was used as a positive control in all experiments. Dothistromin caused a dose-dependent increase in the frequency of gaps and deletions which was not dependent on added metabolic activation. Even at high doses of dothistromin only a very small number of complex exchange-type aberrations were seen. This is in contrast to aflatoxin B1 where such aberrations were seen at low dose levels and especially in cultures to which S9 mix was added. High doses of dothistromin caused culture toxicity manifesting as haemolysis of the donor red blood cells and reduction of mitotic index. Culture toxicity occurred without a marked increase in aberration frequency. This toxicity may be masking any major potential for clastogenicity by dothistromin.
AuthorsL R Ferguson, M I Parslow, J A McLarin
JournalMutation research (Mutat Res) 1986 Apr-May Vol. 170 Issue 1-2 Pg. 47-53 ISSN: 0027-5107 [Print] Netherlands
PMID3083246 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aflatoxins
  • Anthraquinones
  • Mutagens
  • dothistromin
  • Aflatoxin B1
Topics
  • Aflatoxin B1
  • Aflatoxins (adverse effects)
  • Anthraquinones (adverse effects)
  • Cells, Cultured
  • Chemical Phenomena
  • Chemistry
  • Chromosome Aberrations
  • Dose-Response Relationship, Drug
  • Humans
  • Lymphocytes (drug effects)
  • Metaphase (drug effects)
  • Mutagens

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: